Related Experiment Videos
Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice
Abstract:
The hypothesis was tested that the fifth component of complement (C5) was required for the accumulation of macrophages at the site of tumor growth. This was based on the assumption that the cleavage product of C5, C5a, attracts peripheral blood monocytes along a chemotactic gradient. Methylcholanthrene-induced primary and transplanted tumors were grown in the genetically C5-deficient B10.D2/oSn strain and the C5-positive B10.D2/oSn strain and their macrophage content assessed after enzymic disaggregation of the tumors. The overall data indicated that there were no significant differences in the two strains since macrophages accumulated in the tumors irrespective of the presence of C5 or its cleavage product C5a.
Insights
The fifth component of complement (C5) is not essential for macrophage accumulation in tumors. Macrophages were found in tumors regardless of C5 presence, challenging the chemotactic role of C5a.
Area of Science:
- Immunology
- Oncology
- Complement System
Background:
- The complement system plays a role in immune responses, including inflammation and host defense.
- Complement component 5 (C5) and its cleavage product C5a are known chemoattractants for monocytes and macrophages.
- Tumor microenvironments often contain significant macrophage infiltration, influencing tumor progression.
Purpose of the Study:
- To investigate the necessity of the fifth component of complement (C5) for macrophage accumulation at tumor sites.
- To determine if C5a-mediated chemotaxis is a primary driver of macrophage infiltration into tumors.
Main Methods:
- Utilized methylcholanthrene-induced primary and transplanted tumors in mice.
- Employed C5-deficient B10.D2/oSn mice and C5-positive B10.D2/oSn mice for comparative analysis.
- Assessed macrophage content in tumors via enzymic disaggregation and quantification.
Main Results:
- Macrophage accumulation was observed in tumors from both C5-deficient and C5-positive mouse strains.
- No significant differences in tumor macrophage content were detected between the two experimental groups.
- Tumor growth proceeded with substantial macrophage infiltration irrespective of C5 or C5a presence.
Conclusions:
- The fifth component of complement (C5) is not required for the accumulation of macrophages at tumor sites.
- The assumed chemotactic role of C5a in attracting peripheral blood monocytes to tumors was not supported by these findings.
- Alternative or redundant mechanisms likely govern macrophage infiltration into developing tumors.